
The results of the four zzso trials conducted over the past 15 years zzso zzso early zzso therapy with broad spectrum antibiotics directed against zzso bacterial zzso zzso is a reasonable approach in zzso zzso patients zzso zzso the level and dynamics of the zzso count are extremely important in determining the outcome of zzso severely and/or persistently zzso patients are the true tests of zzso efficacy and they benefit from zzso zzso zzso mortality from zzso in zzso is not related directly to a given zzso zzso regimen which may zzso zzso and allow appropriate therapeutic zzso zzso only zzso documented infections and especially zzso are useful to compare responses to zzso zzso zzso the response rate of zzso is clearly influenced by the zzso of the zzso pathogen to the zzso component of the zzso regimen and emergence of resistance to some antibiotics zzso zzso zzso zzso has rendered some combinations less zzso The combination of an zzso zzso plus an zzso is recommended as the zzso for zzso therapy in zzso zzso zzso zzso pathogens have become a common cause of zzso in zzso and although the response rate to zzso regimens may be zzso the associated mortality is zzso A general conclusion from these trials is that studies of the management of infection in zzso should include sufficient numbers of eligible patients to allow for evaluation of zzso patients at highest risk of zzso The need for large collaborative studies stems directly from these zzso 

